Canlyniadau Chwilio - Frank Hulstaert
- Dangos 1 - 11 canlyniadau o 11
-
1
-
2
-
3
-
4
-
5
-
6
Serological Confirmation of Chagas' Disease by a Recombinant and Peptide Antigen Line Immunoassay: INNO-LIA Chagas gan Amadeo Sáez‐Alquézar, Éster Cerdeira Sabino, Nanci A. Salles, Dalton F. Chamone, Frank Hulstaert, Hans Pottel, Erik Stoops, Maan Zrein
Cyhoeddwyd 2000Artigo -
7
Monitoring Drug Resistance in Chronic Hepatitis B Virus (HBV)-Infected Patients during Lamivudine Therapy: Evaluation of Performance of INNO-LiPA HBV DR Assay gan Anna S. Lok, Fabien Zoulim, Stephen Locarnini, Alessandra Mangia, Grazia Anna Niro, Hilde Decraemer, Geert Maertens, Frank Hulstaert, K De Vreese, Erwin Sablon
Cyhoeddwyd 2002Artigo -
8
Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies gan Hugo Vanderstichele, K De Vreese, Kaj Blennow, Niels Andreasen, Christian Sindic, Adrian Ivanoiu, Harald Hampel, Katharina Bürger, Lucilla Parnetti, Alessia Lanari, Alessandro Padovani, Mónica Di Luca, Miriam Bläser, Annika Olsson, Hans Pottel, Frank Hulstaert, Eugeen Vanmechelen
Cyhoeddwyd 2006Artigo -
9
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer gan Robbe Saesen, Mieke Van Hemelrijck, Jan Bogaerts, Christopher M. Booth, Jan J. Cornelissen, André Dekker, Elizabeth A. Eisenhauer, André Freitas, Alessandro Gronchi, Miguel A. Hernán, Frank Hulstaert, Piet Ost, Petr Szturz, Helena M. Verkooijen, Michael Weller, Roger Wilson, Denis Lacombe, Winette T.A. van der Graaf
Cyhoeddwyd 2023Artigo -
10
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system gan Rainer Ziermann, Linda Celis, Inge Derdelinckx, Christine Lambert, Jürgen Veeck, Maria Gabriella Rizzo, Bart Vanderborght, Georges Zissis, Nathan Clumeck, Katrien Fransen, Dolorès Vaira, David A. Hendricks, Kristel Van Laethem, Anne–Mieke Vandamme, Jean-Claude Schmit, Heribert Knechten, Andrea De Luca, Joost Louwagie, Pascale Segers, Kristel De Boeck, Hans Pottel, Annelies De Brauwer, Frank Hulstaert
Cyhoeddwyd 2004Artigo -
11
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial gan Jozefien Declercq, Karel Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Cédric Bosteels, Simon J. Tavernier, Stefanie De Buyser, Roos Colman, Maya Hites, Gil Verschelden, Tom Fivez, Filip Moerman, Ingel Demedts, Nicolás Dauby, Nicolas De Schryver, Elke Govaerts, Stefaan J. Vandecasteele, Johan Van Laethem, Sébastien Anguille, Jeroen C.H. van der Hilst, Benoît Misset, Hans Slabbynck, Xavier Wittebole, F Liénart, Catherine Legrand, Marc Buyse, Dieter Stevens, F Bauters, Leen Seys, Helena Aegerter, Ursula Smole, Victor Bosteels, Levi Hoste, Leslie Naesens, Filomeen Haerynck, Linos Vandekerckhove, Pieter Depuydt, Eva Van Braeckel, Sylvie Rottey, Isabelle Peene, Catherine Van Der Straeten, Frank Hulstaert, Bart N. Lambrecht
Cyhoeddwyd 2021Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Internal medicine
Biology
Immunology
Virology
Computer science
Disease
Business
Clinical trial
Economic growth
Economics
Environmental health
Genetics
Health care
Medical physics
Pharmacology
Population
Randomized controlled trial
2019-20 coronavirus outbreak
Activity-based costing
Acute care
Algorithm
Alzheimer's disease
Antibody
Antiretroviral therapy
Asymptomatic
Authorization
Betacoronavirus
Bioinformatics
Biological drugs